Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices

• Published in: EuroIntervention Vol. 17; no. 4; pp. e274 - e286
• Main Authors: Chieffo, Alaide, Dudek, Dariusz, Hassager, Christian, Combes, Alain, Gramegna, Mario, Halvorsen, Sigrun, Huber, Kurt, Kunadian, Vijay, Maly, Jiri, Møller, Jacob Eifer, Pappalardo, Federico, Tarantini, Giuseppe, Tavazzi, Guido, Thiele, Holger, Vandenbriele, Christophe, Van Mieghem, Nicolas, Vranckx, Pascal, Werner, Nikos, Price, Susanna
• Format: Journal Article
• Language: English
• Published: France EuroPCR 01.07.2021
• Subjects: Cardiovascular System; Consensus; Heart-Assist Devices - adverse effects; Humans; Life Sciences; Percutaneous Coronary Intervention - adverse effects; Shock, Cardiogenic - therapy
• ISSN: 1774-024X; 1969-6213
• DOI: 10.4244/EIJY21M05_01

There has been a significant increase in the use of short-term percutaneous ventricular assist devices (pVADs) as acute circulatory support in cardiogenic shock and to provide haemodynamic support during interventional procedures, including high-risk percutaneous coronary interventions. Although frequently considered together, pVADs differ in their haemodynamic effects, management, indications, insertion techniques, and monitoring requirements. This consensus document summarizes the views of an expert panel by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the Association for Acute Cardiovascular Care (ACVC) and appraises the value of short-term pVAD. It reviews the pathophysiological context and possible indications for pVAD in different clinical settings and provides guidance regarding the management of pVAD based on existing evidence and best current practice.